Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Redox regulation of nitrosyl-hemoglobin in human erythrocytes.

Dei Zotti F, Verdoy R, Brusa D, Lobysheva II, Balligand JL.

Redox Biol. 2019 Dec 5:101399. doi: 10.1016/j.redox.2019.101399. [Epub ahead of print]

2.

Changes of Metabolic Phenotype of Cardiac Progenitor Cells During Differentiation: Neutral Effect of Stimulation of AMP-Activated Protein Kinase.

André E, De Pauw A, Verdoy R, Brusa D, Bouzin C, Timmermans A, Bertrand L, Balligand JL.

Stem Cells Dev. 2019 Nov 15;28(22):1498-1513. doi: 10.1089/scd.2019.0129. Epub 2019 Oct 22.

PMID:
31530214
3.

Increased clusterin levels after myocardial infarction is due to a defect in protein degradation systems activity.

Turkieh A, Porouchani S, Beseme O, Chwastyniak M, Amouyel P, Lamblin N, Balligand JL, Bauters C, Pinet F.

Cell Death Dis. 2019 Aug 13;10(8):608. doi: 10.1038/s41419-019-1857-x.

4.

Classification of the Immune Composition in the Tumor Infiltrate.

Brusa D, Balligand JL.

Methods Mol Biol. 2019;1979:305-315. doi: 10.1007/978-1-4939-9240-9_19.

PMID:
31028646
5.

Phosphatase regulatory subunits in beta-adrenergic signalling: a delicate balancing act.

Balligand JL.

Cardiovasc Res. 2019 Mar 1;115(3):477-478. doi: 10.1093/cvr/cvy275. No abstract available.

PMID:
30423031
6.
7.

Treatments targeting inotropy.

Maack C, Eschenhagen T, Hamdani N, Heinzel FR, Lyon AR, Manstein DJ, Metzger J, Papp Z, Tocchetti CG, Yilmaz MB, Anker SD, Balligand JL, Bauersachs J, Brutsaert D, Carrier L, Chlopicki S, Cleland JG, de Boer RA, Dietl A, Fischmeister R, Harjola VP, Heymans S, Hilfiker-Kleiner D, Holzmeister J, de Keulenaer G, Limongelli G, Linke WA, Lund LH, Masip J, Metra M, Mueller C, Pieske B, Ponikowski P, Ristić A, Ruschitzka F, Seferović PM, Skouri H, Zimmermann WH, Mebazaa A.

Eur Heart J. 2019 Nov 21;40(44):3626-3644. doi: 10.1093/eurheartj/ehy600.

8.

A Belgian consensus strategy to identify familial hypercholesterolaemia in the coronary care unit and its subsequent cascade screening and treatment: BEL-FaHST (The BELgium Familial Hypercholesterolaemia STrategy).

Descamps OS, Van Caenegem O, Hermans MP, Balligand JL, Beauloye C, Bondue A, Carlier S, Castermans E, Chenot F, Claeys M, De Block C, de Leener A, De Meester A, Demeure F, De Raedt H, Desmet W, Elegeert I, Guillaume M, Hoffer E, Kacenelenbogen R, Lancellotti P, Langlois M, Leone A, Mertens A, Paquot N, Vanakker O, Vanoverschelde JL, Verhaegen A, Vermeersch P, Wallemacq C, Rietzschel E; Belgian Atherosclerosis Society/Belgian Lipid Club (BAS/BLC), the Belgian Society of Cardiology (BSC) and the Royal Belgian Society of Laboratory Medicine (RBSLM).

Atherosclerosis. 2018 Oct;277:369-376. doi: 10.1016/j.atherosclerosis.2018.05.037.

9.

Nitrosyl-hemoglobin formation in rodent and human venous erythrocytes reflects NO formation from the vasculature in vivo.

Dei Zotti F, Lobysheva II, Balligand JL.

PLoS One. 2018 Jul 11;13(7):e0200352. doi: 10.1371/journal.pone.0200352. eCollection 2018.

10.

MicroRNA-199a-3p and MicroRNA-199a-5p Take Part to a Redundant Network of Regulation of the NOS (NO Synthase)/NO Pathway in the Endothelium.

Joris V, Gomez EL, Menchi L, Lobysheva I, Di Mauro V, Esfahani H, Condorelli G, Balligand JL, Catalucci D, Dessy C.

Arterioscler Thromb Vasc Biol. 2018 Oct;38(10):2345-2357. doi: 10.1161/ATVBAHA.118.311145.

PMID:
29976767
11.

Rationale and design of a multicentre, randomized, placebo-controlled trial of mirabegron, a Beta3-adrenergic receptor agonist on left ventricular mass and diastolic function in patients with structural heart disease Beta3-left ventricular hypertrophy (Beta3-LVH).

Pouleur AC, Anker S, Brito D, Brosteanu O, Hasenclever D, Casadei B, Edelmann F, Filippatos G, Gruson D, Ikonomidis I, Lhommel R, Mahmod M, Neubauer S, Persu A, Gerber BL, Piechnik S, Pieske B, Pieske-Kraigher E, Pinto F, Ponikowski P, Senni M, Trochu JN, Van Overstraeten N, Wachter R, Balligand JL.

ESC Heart Fail. 2018 Oct;5(5):830-841. doi: 10.1002/ehf2.12306. Epub 2018 Jun 22. Erratum in: ESC Heart Fail. 2018 Dec;5(6):1199.

12.

Metabolic changes in hypertrophic cardiomyopathies: scientific update from the Working Group of Myocardial Function of the European Society of Cardiology.

van der Velden J, Tocchetti CG, Varricchi G, Bianco A, Sequeira V, Hilfiker-Kleiner D, Hamdani N, Leite-Moreira AF, Mayr M, Falcão-Pires I, Thum T, Dawson DK, Balligand JL, Heymans S.

Cardiovasc Res. 2018 Aug 1;114(10):1273-1280. doi: 10.1093/cvr/cvy147. Review.

13.

Expression and Implication of Clusterin in Left Ventricular Remodeling After Myocardial Infarction.

Turkieh A, Fertin M, Bouvet M, Mulder P, Drobecq H, Lemesle G, Lamblin N, de Groote P, Porouchani S, Chwastyniak M, Beseme O, Amouyel P, Mouquet F, Balligand JL, Richard V, Bauters C, Pinet F.

Circ Heart Fail. 2018 Jun;11(6):e004838. doi: 10.1161/CIRCHEARTFAILURE.117.004838.

PMID:
29891738
14.

Studying the Role of AMPK in Cardiac Hypertrophy and Protein Synthesis.

Mailleux F, Beauloye C, Balligand JL, Horman S, Bertrand L.

Methods Mol Biol. 2018;1732:321-342. doi: 10.1007/978-1-4939-7598-3_21.

PMID:
29480485
15.

Can stress make you relax?

Balligand JL, Farah C.

Cardiovasc Res. 2018 Apr 1;114(5):643-644. doi: 10.1093/cvr/cvy027. No abstract available.

PMID:
29438492
16.

Nitric oxide signalling in cardiovascular health and disease.

Farah C, Michel LYM, Balligand JL.

Nat Rev Cardiol. 2018 May;15(5):292-316. doi: 10.1038/nrcardio.2017.224. Epub 2018 Feb 1. Review.

PMID:
29388567
17.

AMPK activation counteracts cardiac hypertrophy by reducing O-GlcNAcylation.

Gélinas R, Mailleux F, Dontaine J, Bultot L, Demeulder B, Ginion A, Daskalopoulos EP, Esfahani H, Dubois-Deruy E, Lauzier B, Gauthier C, Olson AK, Bouchard B, Des Rosiers C, Viollet B, Sakamoto K, Balligand JL, Vanoverschelde JL, Beauloye C, Horman S, Bertrand L.

Nat Commun. 2018 Jan 25;9(1):374. doi: 10.1038/s41467-017-02795-4.

18.

The innate immune system in chronic cardiomyopathy: a European Society of Cardiology (ESC) scientific statement from the Working Group on Myocardial Function of the ESC.

Frantz S, Falcao-Pires I, Balligand JL, Bauersachs J, Brutsaert D, Ciccarelli M, Dawson D, de Windt LJ, Giacca M, Hamdani N, Hilfiker-Kleiner D, Hirsch E, Leite-Moreira A, Mayr M, Thum T, Tocchetti CG, van der Velden J, Varricchi G, Heymans S.

Eur J Heart Fail. 2018 Mar;20(3):445-459. doi: 10.1002/ejhf.1138. Epub 2018 Jan 15. Review.

19.

An integrative translational approach to study heart failure with preserved ejection fraction: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology.

Lourenço AP, Leite-Moreira AF, Balligand JL, Bauersachs J, Dawson D, de Boer RA, de Windt LJ, Falcão-Pires I, Fontes-Carvalho R, Franz S, Giacca M, Hilfiker-Kleiner D, Hirsch E, Maack C, Mayr M, Pieske B, Thum T, Tocchetti CG, Brutsaert DL, Heymans S.

Eur J Heart Fail. 2018 Feb;20(2):216-227. doi: 10.1002/ejhf.1059. Epub 2017 Nov 16. Review.

20.

Cardiac myocyte β3-adrenergic receptors prevent myocardial fibrosis by modulating oxidant stress-dependent paracrine signaling.

Hermida N, Michel L, Esfahani H, Dubois-Deruy E, Hammond J, Bouzin C, Markl A, Colin H, Steenbergen AV, De Meester C, Beauloye C, Horman S, Yin X, Mayr M, Balligand JL.

Eur Heart J. 2018 Mar 7;39(10):888-898. doi: 10.1093/eurheartj/ehx366.

PMID:
29106524
21.

The Function and Therapeutic Potential of Long Non-coding RNAs in Cardiovascular Development and Disease.

Gomes CPC, Spencer H, Ford KL, Michel LYM, Baker AH, Emanueli C, Balligand JL, Devaux Y; Cardiolinc network.

Mol Ther Nucleic Acids. 2017 Sep 15;8:494-507. doi: 10.1016/j.omtn.2017.07.014. Epub 2017 Jul 28. Review.

22.

Dnmt3a-mediated inhibition of Wnt in cardiac progenitor cells improves differentiation and remote remodeling after infarction.

De Pauw A, Andre E, Sekkali B, Bouzin C, Esfahani H, Barbier N, Loriot A, De Smet C, Vanhoutte L, Moniotte S, Gerber B, di Mauro V, Catalucci D, Feron O, Hilfiker-Kleiner D, Balligand JL.

JCI Insight. 2017 Jun 15;2(12). pii: 91810. doi: 10.1172/jci.insight.91810. eCollection 2017 Jun 15.

24.

Clinical and biochemical data of endothelial function in Women Consuming Combined Contraceptives.

Lobysheva II, Eeckhoudt SV, Zotti FD, Rifahi A, Pothen L, Beauloye C, Balligand JL.

Data Brief. 2017 May 12;13:46-52. doi: 10.1016/j.dib.2017.05.019. eCollection 2017 Aug.

25.

Heme-nitrosylated hemoglobin and oxidative stress in women consuming combined contraceptives. Clinical application of the EPR spectroscopy.

Lobysheva II, van Eeckhoudt S, Dei Zotti F, Rifahi A, Pothen L, Beauloye C, Balligand JL.

Free Radic Biol Med. 2017 Jul;108:524-532. doi: 10.1016/j.freeradbiomed.2017.03.039. Epub 2017 Apr 7.

PMID:
28392282
26.

MRI Assessment of Cardiomyopathy Induced by β1-Adrenoreceptor Autoantibodies and Protection Through β3-Adrenoreceptor Overexpression.

Vanhoutte L, Guilbaud C, Martherus R, Bouzin C, Gallez B, Dessy C, Balligand JL, Moniotte S, Feron O.

Sci Rep. 2017 Mar 9;7:43951. doi: 10.1038/srep43951.

27.

Cardiac beta3-adrenergic receptors in the clinical arena: the end of the beginning.

Balligand JL.

Eur J Heart Fail. 2017 Apr;19(4):576-578. doi: 10.1002/ejhf.784. Epub 2017 Feb 15. No abstract available.

28.

Sodium-myoinositol cotransporter-1, SMIT1, mediates the production of reactive oxygen species induced by hyperglycemia in the heart.

Van Steenbergen A, Balteau M, Ginion A, Ferté L, Battault S, Ravenstein CM, Balligand JL, Daskalopoulos EP, Gilon P, Despa F, Despa S, Vanoverschelde JL, Horman S, Koepsell H, Berry G, Hue L, Bertrand L, Beauloye C.

Sci Rep. 2017 Jan 27;7:41166. doi: 10.1038/srep41166.

29.

New and Emerging Therapies and Targets: Beta-3 Agonists.

Michel LYM, Balligand JL.

Handb Exp Pharmacol. 2017;243:205-223. doi: 10.1007/164_2016_88. Review.

PMID:
28035527
30.

Paracrine nitric oxide induces expression of cardiac sarcomeric proteins in adult progenitor cells through soluble guanylyl cyclase/cyclic-guanosine monophosphate and Wnt/β-catenin inhibition.

De Pauw A, Massion P, Sekkali B, Andre E, Dubroca C, Kmecova J, Bouzin C, Friart A, Sibille C, Gilon P, De Mulder D, Esfahani H, Strapart A, Martherus R, Payen V, Sonveaux P, Brouckaert P, Janssens S, Balligand JL.

Cardiovasc Res. 2016 Oct;112(1):478-90. doi: 10.1093/cvr/cvw196. Epub 2016 Aug 12.

PMID:
27520736
31.

Erratum to: High field magnetic resonance imaging of rodents in cardiovascular research.

Vanhoutte L, Gerber BL, Gallez B, Po C, Magat J, Balligand JL, Feron O, Moniotte S.

Basic Res Cardiol. 2016 Sep;111(5):55. doi: 10.1007/s00395-016-0572-3. No abstract available.

PMID:
27492500
32.

High field magnetic resonance imaging of rodents in cardiovascular research.

Vanhoutte L, Gerber BL, Gallez B, Po C, Magat J, Balligand JL, Feron O, Moniotte S.

Basic Res Cardiol. 2016 Jul;111(4):46. doi: 10.1007/s00395-016-0565-2. Epub 2016 Jun 10. Review. Erratum in: Basic Res Cardiol. 2016 Sep;111(5):55.

PMID:
27287250
33.

Loss of Mouse P2Y6 Nucleotide Receptor Is Associated with Physiological Macrocardia and Amplified Pathological Cardiac Hypertrophy.

Clouet S, Di Pietrantonio L, Daskalopoulos EP, Esfahani H, Horckmans M, Vanorlé M, Lemaire A, Balligand JL, Beauloye C, Boeynaems JM, Communi D.

J Biol Chem. 2016 Jul 22;291(30):15841-52. doi: 10.1074/jbc.M115.684118. Epub 2016 May 26.

34.

Cardiac salvage by tweaking with beta-3-adrenergic receptors.

Balligand JL.

Cardiovasc Res. 2016 Jul 15;111(2):128-33. doi: 10.1093/cvr/cvw056. Epub 2016 Mar 21. Review.

PMID:
27001422
35.

β-Adrenergic Receptors Cooperate With Transcription Factors: The "STAT" of Their Union.

Balligand JL.

Circulation. 2016 Jan 5;133(1):4-7. doi: 10.1161/CIRCULATIONAHA.115.019860. Epub 2015 Dec 1. No abstract available.

PMID:
26628620
36.

KLF6 orchestrates cardiac myocyte-to-fibroblast communication: 'He who has ears to hear, let him hear'.

Balligand JL.

Cardiovasc Res. 2015 Sep 1;107(4):397-9. doi: 10.1093/cvr/cvv189. Epub 2015 Jul 2. No abstract available.

PMID:
26139526
37.

Variability of Mouse Left Ventricular Function Assessment by 11.7 Tesla MRI.

Vanhoutte L, Gallez B, Feron O, Balligand JL, Esfahani H, d'Hoore W, Moniotte S.

J Cardiovasc Transl Res. 2015 Aug;8(6):362-71. doi: 10.1007/s12265-015-9638-0. Epub 2015 Jun 13.

PMID:
26070905
38.

Loss of mouse P2Y4 nucleotide receptor protects against myocardial infarction through endothelin-1 downregulation.

Horckmans M, Esfahani H, Beauloye C, Clouet S, di Pietrantonio L, Robaye B, Balligand JL, Boeynaems JM, Dessy C, Communi D.

J Immunol. 2015 Feb 15;194(4):1874-81. doi: 10.4049/jimmunol.1401364. Epub 2015 Jan 16.

39.

Living Donor Liver Transplantation in Children: Surgical and Immunological Results in 250 Recipients at Université Catholique de Louvain.

Gurevich M, Guy-Viterbo V, Janssen M, Stephenne X, Smets F, Sokal E, Lefebvre C, Balligand JL, Pirotte T, Veyckemans F, Clapuyt P, Menten R, Dumitriu D, Danse E, Annet L, Clety SC, Detaille T, Latinne D, Sempoux C, Laterre PF, de Magnée C, Lerut J, Reding R.

Ann Surg. 2015 Dec;262(6):1141-9. doi: 10.1097/SLA.0000000000001094.

PMID:
25563870
40.

Chronic β1-adrenergic blockade enhances myocardial β3-adrenergic coupling with nitric oxide-cGMP signaling in a canine model of chronic volume overload: new insight into mechanisms of cardiac benefit with selective β1-blocker therapy.

Trappanese DM, Liu Y, McCormick RC, Cannavo A, Nanayakkara G, Baskharoun MM, Jarrett H, Woitek FJ, Tillson DM, Dillon AR, Recchia FA, Balligand JL, Houser SR, Koch WJ, Dell'Italia LJ, Tsai EJ.

Basic Res Cardiol. 2015 Jan;110(1):456. doi: 10.1007/s00395-014-0456-3. Epub 2014 Dec 6.

41.

Involvement of nitric oxide in iodine deficiency-induced microvascular remodeling in the thyroid gland: role of nitric oxide synthase 3 and ryanodine receptors.

Craps J, Wilvers C, Joris V, De Jongh B, Vanderstraeten J, Lobysheva I, Balligand JL, Sonveaux P, Gilon P, Many MC, Gérard AC, Colin IM.

Endocrinology. 2015 Feb;156(2):707-20. doi: 10.1210/en.2014-1729. Epub 2014 Nov 18.

PMID:
25406019
42.

Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPKα1.

Noppe G, Dufeys C, Buchlin P, Marquet N, Castanares-Zapatero D, Balteau M, Hermida N, Bouzin C, Esfahani H, Viollet B, Bertrand L, Balligand JL, Vanoverschelde JL, Beauloye C, Horman S.

J Mol Cell Cardiol. 2014 Sep;74:32-43. doi: 10.1016/j.yjmcc.2014.04.018. Epub 2014 May 5.

PMID:
24805196
43.

A-769662 potentiates the effect of other AMP-activated protein kinase activators on cardiac glucose uptake.

Timmermans AD, Balteau M, Gélinas R, Renguet E, Ginion A, de Meester C, Sakamoto K, Balligand JL, Bontemps F, Vanoverschelde JL, Horman S, Beauloye C, Bertrand L.

Am J Physiol Heart Circ Physiol. 2014 Jun 15;306(12):H1619-30. doi: 10.1152/ajpheart.00965.2013. Epub 2014 Apr 18.

44.

Targeting myocardial remodelling to develop novel therapies for heart failure: a position paper from the Working Group on Myocardial Function of the European Society of Cardiology.

Tarone G, Balligand JL, Bauersachs J, Clerk A, De Windt L, Heymans S, Hilfiker-Kleiner D, Hirsch E, Iaccarino G, Knöll R, Leite-Moreira AF, Lourenço AP, Mayr M, Thum T, Tocchetti CG.

Eur J Heart Fail. 2014 May;16(5):494-508. doi: 10.1002/ejhf.62. Epub 2014 Mar 17. Review.

45.

Transgenic mice for real-time visualization of cGMP in intact adult cardiomyocytes.

Götz KR, Sprenger JU, Perera RK, Steinbrecher JH, Lehnart SE, Kuhn M, Gorelik J, Balligand JL, Nikolaev VO.

Circ Res. 2014 Apr 11;114(8):1235-45. doi: 10.1161/CIRCRESAHA.114.302437. Epub 2014 Mar 5.

PMID:
24599804
46.

ESC Working Group on Myocardial Function Position Paper: how to study the right ventricle in experimental models.

Leite-Moreira AF, Lourenço AP, Balligand JL, Bauersachs J, Clerk A, De Windt LJ, Heymans S, Hilfiker-Kleiner D, Hirsch E, Iaccarino G, Kaminski KA, Knöll R, Mayr M, Tarone G, Thum T, Tocchetti CG.

Eur J Heart Fail. 2014 May;16(5):509-18. doi: 10.1002/ejhf.66. Epub 2014 Feb 23. Review.

47.

Enhanced expression of β3-adrenoceptors in cardiac myocytes attenuates neurohormone-induced hypertrophic remodeling through nitric oxide synthase.

Belge C, Hammond J, Dubois-Deruy E, Manoury B, Hamelet J, Beauloye C, Markl A, Pouleur AC, Bertrand L, Esfahani H, Jnaoui K, Götz KR, Nikolaev VO, Vanderper A, Herijgers P, Lobysheva I, Iaccarino G, Hilfiker-Kleiner D, Tavernier G, Langin D, Dessy C, Balligand JL.

Circulation. 2014 Jan 28;129(4):451-62. doi: 10.1161/CIRCULATIONAHA.113.004940. Epub 2013 Nov 4.

PMID:
24190960
48.

Nitrosylated hemoglobin levels in human venous erythrocytes correlate with vascular endothelial function measured by digital reactive hyperemia.

Lobysheva II, Biller P, Gallez B, Beauloye C, Balligand JL.

PLoS One. 2013 Oct 10;8(10):e76457. doi: 10.1371/journal.pone.0076457. eCollection 2013.

49.

Melusin protects from cardiac rupture and improves functional remodelling after myocardial infarction.

Unsöld B, Kaul A, Sbroggiò M, Schubert C, Regitz-Zagrosek V, Brancaccio M, Damilano F, Hirsch E, Van Bilsen M, Munts C, Sipido K, Bito V, Detre E, Wagner NM, Schäfer K, Seidler T, Vogt J, Neef S, Bleckmann A, Maier LS, Balligand JL, Bouzin C, Ventura-Clapier R, Garnier A, Eschenhagen T, El-Armouche A, Knöll R, Tarone G, Hasenfuß G.

Cardiovasc Res. 2014 Jan 1;101(1):97-107. doi: 10.1093/cvr/cvt235. Epub 2013 Oct 15.

50.

Reducing damage through Nrf-2.

Balligand JL.

Cardiovasc Res. 2013 Oct 1;100(1):1-3. doi: 10.1093/cvr/cvt204. Epub 2013 Aug 22. No abstract available.

PMID:
23970486

Supplemental Content

Loading ...
Support Center